title: Differential response of chronic plaque psoriasis to briakinumab vs. ustekinumab.
authors.affiliation: Department of Dermatology, Medical University of Graz, Auenbruggerplatz 8, AT-8036 Graz, Austria.
authors.forename: Martin
authors.initials: M
authors.lastname: Inzinger
authors.forename: Wolfgang
authors.initials: W
authors.lastname: Weger
authors.forename: Wolfgang
authors.initials: W
authors.lastname: Salmhofer
authors.forename: Peter
authors.initials: P
authors.lastname: Wolf
mesh_terms: D000328:Adult; D000893:Anti-Inflammatory Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D000911:Antibodies, Monoclonal / Q000008:administration & dosage / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D002908:Chronic Disease; D006801:Humans; D008297:Male; D011565:Psoriasis / Q000175:diagnosis / Q000188:drug therapy* / Q000276:immunology; D012074:Remission Induction; D016896:Treatment Outcome; D000069549:Ustekinumab
chemical_list: D000893:Anti-Inflammatory Agents; D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; C544528:briakinumab; D000069549:Ustekinumab